Skip to content
August 15, 2022

Equity.Guru

Investment information for the new generation

pediatric sector

MediWound (MDWD.Q), a biopharmaceutical company focused on developing solutions for tissue repair and regeneration, today announced positive topline results from its pivotal phase 3 pediatric clinical study (CIDS – Children…